Cargando…

Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation

The role of donor and recipient Coronavirus disease 2019 (COVID-19) immunologic status pre-transplantation has not been fully investigated in allogeneic hematopoietic stem cell transplantation (HSCT) recipients. Given the poor immunogenicity to vaccines in this population and the serious outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherman, Amy C., Cheng, Chi-An, Swank, Zoe, Zhou, Guohai, Li, Xiaofang, Issa, Nicolas C., Walt, David R., Baden, Lindsey R., Soiffer, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023
Materias:	Brief Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891788/ https://www.ncbi.nlm.nih.gov/pubmed/36736784 http://dx.doi.org/10.1016/j.jtct.2023.01.025

Ejemplares similares

100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant
por: Mitre, Xhoi, et al.
Publicado: (2021)

Infection in the Hematopoietic Stem Cell Transplant Recipient
por: Marty, Francisco M., et al.
Publicado: (2008)

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients
por: Aleissa, Muneerah M., et al.
Publicado: (2023)

1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Baumrin, Emily, et al.
Publicado: (2018)

25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
por: Bausk, Bruce P, et al.
Publicado: (2021)

1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients
por: Kokogho, Afoke, et al.
Publicado: (2023)

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant
por: Desjardins, Michaël, et al.
Publicado: (2021)

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation
por: Gibson, Christopher J., et al.
Publicado: (2022)

1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients
por: Pandit, Alisha, et al.
Publicado: (2018)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
por: Olearo, Flaminia, et al.
Publicado: (2020)

COVID-19 in orthotopic heart transplant recipients and association with donor specific antibodies
por: Yang, Bin Q., et al.
Publicado: (2022)

Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Sadanand, Arhanti, et al.
Publicado: (2019)

Probable Donor-Derived Human Adenovirus Type 34 Infection in 2 Kidney Transplant Recipients From the Same Donor
por: Pettengill, Matthew A, et al.
Publicado: (2018)

The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
por: Woolley, Ann E., et al.
Publicado: (2022)

Pregnancy in renal transplantation: Recipient and donor aspects in the Arab world
por: Kukla, Aleksandra, et al.
Publicado: (2012)

Return-to-School Practices for Pediatric Hematopoietic Cell Transplantation Recipients during the COVID-19 Pandemic
por: Bhatt, Neel S., et al.
Publicado: (2022)

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Chavaz, Lara, et al.
Publicado: (2023)

Detection of Adeno-Associated Virus Viremia in Hematopoietic Cell Transplant Recipients
por: Heugel, Judson, et al.
Publicado: (2011)

Comparison of donor‐derived cell‐free DNA between single versus double lung transplant recipients
por: Keller, Michael B., et al.
Publicado: (2022)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus
por: Waghmare, Alpana, et al.
Publicado: (2017)

36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation
por: Baumrin, Emily, et al.
Publicado: (2020)

24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients
por: Powell, Megan, et al.
Publicado: (2021)

2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes
por: Kovac, Victor, et al.
Publicado: (2023)

Recipient Hepatic Vein as an Autologous Vascular Graft for Hepatic Vein Reconstruction in Living Donor Liver Transplantation
por: Kato, Yutaro, et al.
Publicado: (2020)

Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience
por: Yeshurun, M., et al.
Publicado: (2010)

Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Kim, Jeong Min, et al.
Publicado: (2023)

Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile
por: Kumar, Ranjit, et al.
Publicado: (2017)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors)
por: Arabi, Ziad, et al.
Publicado: (2020)

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients
por: Gama, Bianca E., et al.
Publicado: (2017)

Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Lee, Sae-Mi, et al.
Publicado: (2017)

Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms
por: Tran, Mya, et al.
Publicado: (2023)

Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients
por: Erickson, Jami R., et al.
Publicado: (2022)

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Unexpected Mycoplasma hominis infection in two renal transplant recipients traced back to the same donor by whole-genome sequencing
por: Hinić, V., et al.
Publicado: (2020)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach
por: Wittenbecher, Friedrich, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ni1nb0ecfv45st0vnjqfd3hf8